SEATTLE, May 24, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing RISE Life Science Corp. (CSE:RLSC), the importance of consistent high quality in the emerging cannabis market, and the company’s commitment to best practices, ingredients, and science.
As the cannabis industry matures, both in North America and across the globe, regulations and consumer demands will require companies to produce consistent, high quality products that are safe and effective. Gone are the days of illicit weed grown with questionable practices, as the black market is being replaced by regulated operations offering a variety of cannabis products scientifically developed for use in distinct applications. With the wide variety of strains and chemical profiles now available to companies making legal cannabis products, a commitment to sourcing quality plants and developing scientifically researched products tailored for a range of needs is more important than ever.
RISE Life Science is a prime example of a company committed to quality from start to finish. RISE is creating a line of cannabis-derived sexual health and wellness products that it intends to market globally, starting in California. From sourcing the best cannabis strains, to rigorous research and development standards, to the commencement of a major cannabis/sexual health study , the company is committed to the highest standards throughout the entire life cycle of product development.
Quality Starts with the Plant
Working toward the highest level of quality, RISE plans to use the best plant sources for the consumer products it develops. As such, the company is exploring a comprehensive supply partnership with Jamaican premium strain producers who meet standards for CGMP (current good manufacturing processes) as set out by the FDA. These standards are designed to assure that quality is built into the design and manufacturing process at every step; facilities are in good condition; equipment is properly maintained and calibrated; employees are qualified and fully trained; and, processes are reliable and reproducible.
Jamaica is not only considered one of the best growing regions in the world, it is also viewed as one of the most experienced, producing cannabis for well over 400 years. With such a deeply established botanical relationship it is no surprise that Jamaican marijuana strains are widely recognized as some of the highest quality in the world.
RISE is targeting strains with the appropriate terpene and cannabinoid profiles to form the basis for its medical line of products to ensure that only the highest quality raw material is utilized in the formulation and development process.
Laboratory Science Important for RISE
RISE Life Science is partnered with experts in the manufacture of premium medical cannabis extract products for physician and patient use. They are leveraging deep experience with whole plant extracts utilizing proprietary extraction and compounding methods.
RISE is launching in California, but has its eyes on markets around the world. International certification is important for companies pursuing global market opportunities. With a patchwork of regulatory demands across markets, the company is seeking the highest-regarded quality control standards in another indication of RISE’s commitment to quality and global acceptance for its products.
“Validated science is at the core of our product development,” said Anton Mattadeen, CEO of RISE. “Our focus is on producing pharmaceutical grade product derived from highly-controlled processes that are continually supported by a feedback of observational data.”
The formulations of RISE products also draw heavily from botanical traditions. To this end, the company’s product formulation strategy relies on herbal specialists based out of Colorado. RISE’s lead herbalist brings 30 years of experience to the company’s product development.
Sexual Health Study Underpins Product Development
Future products will be developed with insights gained from a proprietary research study RISE will launch this fall. It will be the largest observational study of its kind, looking at the effect of cannabis health products on sexual health, behaviors, and performance.
The RISE Report on Cannabis and Sexual Health and Wellness intends to answer many questions that have gone unanswered, and unstudied, as a result of the long-term prohibition of cannabis and research related to the plant. Starting with about 200 beta participants, the study will expand to thousands of people and the data derived should be valuable in a number of ways.
“We are investing in this study because it is central to the ongoing development of consumer products that individuals and couples believe in and actually want to use,” continued Mattadeen. “The proprietary data generated by this study will not only add necessary information to the subject of sexual health, it will also inform RISE of the best possible product development decisions to meet the needs of our customers, provide us with a competitive advantage in the marketplace, and help us remain right in the middle of this important conversation with our expanding consumer community.”
For RISE, the most obvious benefit will lie in how the findings can inform and improve the company’s own product development. The company views this outcome as a competitive advantage in a market rife with un-researched products and wild claims of efficacy. The data would also add more generally to the growing library of science surrounding cannabis, potentially adding more credence to the idea of using the plant as a legitimate treatment and eliminating some of the social taboos around both marijuana and sex.
All told, RISE Life Science is demonstrating its commitment to quality ingredients, practices, and products based on the science of cannabis. With an initial product launch coming soon in California, keep an eye out for further developments in RISE’s quest to legitimize cannabis as a tool to improve lives of consumers and patients wherever the law allows.
Please follow the link to read the full article: http://www.cannabisfn.com/rise-life-science-c...-wellness/
About CFN Media
CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany
Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id...1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
CFN Media
Frank Lane
206-369-7050
flane@cannabisfn.com
